Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

FDA approves Aklief cream for topical treatment of acne

Oct. 7, 2019

Shire Human Genetic Therapies presents new kallikrein B inhibitors

Oct. 7, 2019

Cabaletta Bio receives FDA IND clearance to initiate first-in-human study of DSG3-CAART

Oct. 2, 2019

AnaptysBio reports phase II interim data on ANB-019 in generalized pustular psoriasis

Oct. 1, 2019

Pfizer announces topline results from pivotal JADE MONO-2 study of abrocitinib

Sep. 30, 2019

First patient dosed in phase III TRuE-V clinical trial program of ruxolitinib cream

Sep. 26, 2019

Galapagos initiates phase I trial with GLPG-3970

Sep. 26, 2019

Phase III study of StrataGraft regenerative tissue meets both primary endpoints

Sep. 25, 2019

Bristol-Myers Squibb designs RORgammaT inverse agonists showing biologic-like efficacy

Sep. 9, 2019

Krystal Biotech initiates phase I/II study of topical KB-105 gene therapy for TGM1-deficient ARCI

Sep. 2, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...